Dolby Laboratories, Inc. vs ResMed Inc. — how do they compare? Dolby Laboratories, Inc. trades at $60.91 (market cap $5.75B), while ResMed Inc. trades at $220.4 (market cap $32.61B). The key difference: ResMed Inc. is far larger — about 5.7× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays the higher dividend (2.35%). Which is the better fit depends on your goals.
| DLB | RMD | |
|---|---|---|
Market Cap | $5.75B | $32.61B |
Sector | Industrials | Health |
52-Week High | $75.62 | $293.73 |
52-Week Low | $48.51 | $182.82 |
Enterprise Value | $5.12B | $31.97B |
Dividend Yield | 2.35% | 1.17% |
Trailing returns across standard periods
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →